Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity

Abstract

CirAEs evaluated by dermatologists were significantly more likely to be treated than cirAEs that were not referred, and patients who received any treatment for a cirAE had improved survival outcomes.